2025-05-02 08:43:12
Latest Post
Godrej Agrovet Limited consolidated Q4FY25 net profit drops QoQ to Rs. 70.78 crores
L G Balakrishnan & Bros Ltd posts Rs. 84.03 crores consolidated profit in Q4FY25
Swastika Investmart Ltd Q4 FY2025 consolidated profit slumps to Rs. 27.17 lakhs
Vertex Securities Ltd consolidated Q4 FY25 loss at Rs. 53.99 lakhs
The Federal Bank Limited consolidated Q4FY25 PAT jumps to Rs. 1108.31 crores
Stock Report
Orchid Pharma Ltd Q4 FY2022-23 consolidated net profit jumps to Rs. 59.13 crores
Posted On : 2023-05-10 23:52:04( TIMEZONE : IST )
Orchid Pharma Limited has reported Consolidated financial results for the period ended March 31, 2023.
Financial Results (Q4 FY2023) - QoQ Comparison
The company has reported total income of Rs. 211.6295 crores during the period ended March 31, 2023 as compared to Rs. 168.6913 crores during the period ended December 31, 2022.
The company has posted net profit / (loss) of Rs. 59.1397 crores for the period ended March 31, 2023 as against net profit / (loss) of Rs. 7.5869 crores for the period ended December 31, 2022.
The company has reported EPS of Rs. 14.49 for the period ended March 31, 2023 as compared to Rs. 1.86 for the period ended December 31, 2022.
| Financials | Q4 FY2023 | Q3 FY2023 | % Change |
| Total Income | ₹211.6295 crs | ₹168.6913 crs |  25.45% |
| Net Profit | ₹59.1397 crs | ₹7.5869 crs | 679.50% |
| EPS | ₹14.49 | ₹1.86 | 679.03% |
Financial Results (Q4 FY2023) - YoY Comparison
The company has reported total income of Rs.211.6295 crores during the period ended March 31, 2023 as compared to Rs.179.8792 crores during the period ended March 31, 2022.
The company has posted net profit / (loss) of Rs.59.1397 crores for the period ended March 31, 2023 as against net profit / (loss) of Rs.-6.5864 crores for the period ended March 31, 2022.
The company has reported EPS of Rs.14.49 for the period ended March 31, 2023 as compared to Rs.-1.61 for the period ended March 31, 2022.
| Financials | Q4 FY2023 | Q4 FY2022 | % Change |
| Total Income | ₹211.6295 crs | ₹179.8792 crs | 17.65% |
| Net Profit | ₹59.1397 crs | ₹-6.5864 crs | 997.91% |
| EPS | ₹14.49 | ₹-1.61 | 1,000.00% |
Financial Results (Year Ended FY2023) - YoY Comparison
The company has reported total income of Rs.685.3289 crores during the Financial Year ended March 31, 2023 as compared to Rs.568.5603 crores during the Financial Year ended March 31, 2022.
The company has posted net profit / (loss) of Rs.46.3183 crores for the Financial Year ended March 31, 2023 as against net profit / (loss) of Rs.-1.9512 crores for the Financial Year ended March 31, 2022.
The company has reported EPS of Rs.11.35 for the Financial Year ended March 31, 2023 as compared to Rs.-0.48 for the Financial Year ended March 31, 2022.
| Financials | Year Ended FY2023 | Year Ended FY2022 | % Change |
| Total Income | ₹685.3289 crs | ₹568.5603 crs | 20.54% |
| Net Profit | ₹46.3183 crs | ₹-1.9512 crs | 2,473.84% |
| EPS | ₹11.35 | ₹-0.48 | 2,464.58% |
Shares of Orchid Pharma Limited was last trading in BSE at Rs. 397.35 as compared to the previous close of Rs. 408.90. The total number of shares traded during the day was 498 in over 17 trades.
The stock hit an intraday high of Rs. 403.95 and intraday low of 395.00. The net turnover during the day was Rs. 198913.00.
